This article presents the first sucsessful experience in our country in treating the newborn with sepsis, presumably caused by Escherichia coli, using Efferon LPS NEO pediatric hemoperfusion device.Funding.The study had no sponsor support. Conflict of interest.The authors declare no conflict of interest.
No takes yet. Share an insight, caveat, or question.
Makulova et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: